Iovance Biotherapeutics IOVA
NASDAQ IOVA
$14.44 +3.45 (+31.35%)
As of: Sep 29, 2026 · 3:59 PM EDT

Iovance Biotherapeutics (IOVA) Shares Outstanding (Entity) (2010 - 2026)

Updated

Iovance Biotherapeutics (IOVA) recorded Shares Outstanding (Entity) of 452.97 million in Q2 2026, up 32.5% from 341.92 million a year earlier and up 3.4% from the prior quarter.

Analysis

Iovance Biotherapeutics (IOVA) Shares Outstanding (Entity) (2010 - 2026) Analysis & Trends

For FY2025, Iovance Biotherapeutics reported Shares Outstanding (Entity) of 411.94 million, up 35.0% from FY2024.

  • Annual Shares Outstanding (Entity) has increased for four straight years, with a five-year compound annual growth rate of 395.2% (FY2020 to FY2025).
  • Across earlier years, Shares Outstanding (Entity) came in at 305.25 million in FY2024 (+19.2%), 256.14 million in FY2023 (+36.4%), 187.81 million in FY2022 (+19.6%) and 157 million in FY2021.
  • The Q2 2026 figure is the highest quarterly Shares Outstanding (Entity) in data going back to Q3 2010.
  • On a year-over-year basis, Shares Outstanding (Entity) has increased for 17 consecutive quarters, with growth averaging 24.7% over the last eight quarters.
  • The year-over-year growth in Shares Outstanding (Entity) has ranged between 0.7% (Q3 2022) and 62.1% (Q3 2023) over the last five years.
  • Per Business Quant, the preceding three quarters came in at 438.11 million (Q1 2026), 411.94 million (Q4 2025) and 385.46 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Entity.) (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 2.41 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 1.77 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 2.47 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 540.60 Mn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 1.24 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 5.70 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 253.35 Mn
10 Iovance Biotherapeutics 4.98 Bn 3.77 Bn 55.72 Mn 452.97 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 452.97 Mn
Mar 31, 2026 438.11 Mn
Dec 31, 2025 411.94 Mn
Sep 30, 2025 385.46 Mn
Jun 30, 2025 341.92 Mn
Mar 31, 2025 333.93 Mn
Dec 31, 2024 305.25 Mn
Sep 30, 2024 304.62 Mn
Jun 30, 2024 297.31 Mn
Mar 31, 2024 279.76 Mn
Dec 31, 2023 256.14 Mn
Sep 30, 2023 255.83 Mn
Jun 30, 2023 224.69 Mn
Mar 31, 2023 224.36 Mn
Dec 31, 2022 187.81 Mn
Sep 30, 2022 157.84 Mn
Jun 30, 2022 157.80 Mn
Mar 31, 2022 157.17 Mn
Dec 31, 2021 157.00 Mn
Sep 30, 2021 156.70 Mn
API Access

Iovance Biotherapeutics Shares Outstanding (Entity) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=IOVA&period=max&api_key=YOUR_API_KEY